CoChat

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury

Open access
Krishnan, Anuradha, Ozturk, Nazli Begum, Cutshaw, Kaiyel A., Guicciardi, Maria Eugenia, Kitagataya, Takashi, Olson, Kirsta E., Pavelko, Kevin D., Sherman, William, Wixom, Alexander Q., Jalan-Sakrikar, Nidhi, Baez-Faria, Michelle, Gutierrez, Florencia, Gores, Gregory J. · 2024 · Scientific Reports

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Ductular reactive (DR) cells exacerbate cholestatic liver injury and fibrosis. Herein, we posit that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) emanates from recruited macrophages and restrains DR cell expansion, thereby limiting cholestatic liver injury. Wild type (WT), Trailfl/fl and myeloid-specific Trail deleted (TrailΔmye) C57BL/6 mice were exposed to DDC diet-induced cholestatic liver injury, which induced hepatomegaly and liver injury as compared to control diet-fed mice. However, parameters of liver injury, fibrosis, and inflammation were all increased in the TrailΔmye mice as compared to the WT and Trailfl/fl mice. High dimensional mass cytometry indicated that cholestasis resulted in increased hepatic recruitment of subsets of macrophages and neutrophils in the TrailΔmye mice. Spatial transcriptomics analysis revealed that the PanCK+ cholangiocytes from TrailΔmye mice had increased expression of the known myeloid attractants S100a8, Cxcl5, Cx3cl1, and Cxcl1. Additionally, in situ hybridization of Cxcl1, a potent neutrophil chemoattractant, demonstrated an increased expression in CK19+ cholangiocytes of TrailΔmye mice. Collectively, these data suggest that TRAIL from myeloid cells, particularly macrophages, restrains a subset of DR cells (i.e., Cxcl1 positive cells), limiting liver inflammation and fibrosis. Reprogramming macrophages to express TRAIL may be salutary in cholestasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-52710-3

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Deletion of TRAIL in myeloid cells augments liver injury and portal inflammation. (A) Tnfsf10 (TRAIL) mRNA was decreased in the liver of the TrailΔmye mice as determined by quantitative real-time PCR. (B) Schematic of the experimental timeline illustrating the intermittent feeding schedule with alternating days of DDC/control and chow diet. Morphological attributes and clinical features of liver injury and malfunction are graphically presented (C) Body weight, (D) liver weight expressed as percent of body weight, (E) ALP, (F) ALT (G) total bilirubin, and (H) cholesterol (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001). (I) H&E-stained liver sections showing protoporphyrin (black arrows) in obstructed bile ducts. Dashed lines encompass the area of liver injury and inflammation in the DDC-fed mice. Zoomed images show the extent of injury and inflammation around the portal vein. PV Portal vein. Scale bar = 50 µm.
Figure 1 Deletion of TRAIL in myeloid cells augments liver injury and portal inflammation. (A) Tnfsf10 (TRAIL) mRNA was decreased in the liver of the TrailΔmye mice as determined by quantitative real-time PCR. (B) Schematic of the experimental timeline illustrating the intermittent feeding schedule with alternating days of DDC/control and chow diet. Morphological attributes and clinical features of liver injury and malfunction are graphically presented (C) Body weight, (D) liver weight expressed as percent of body weight, (E) ALP, (F) ALT (G) total bilirubin, and (H) cholesterol (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001). (I) H&E-stained liver sections showing protoporphyrin (black arrows) in obstructed bile ducts. Dashed lines encompass the area of liver injury and inflammation in the DDC-fed mice. Zoomed images show the extent of injury and inflammation around the portal vein. PV Portal vein. Scale bar = 50 µm.CC BY · PubMed Central
Figure 2 Ductular reaction and fibrosis are increased in cholestatic mice. (A) Representative images of FPPE liver tissue sections from WT, Trailfl/fl, and TrailΔmye mice were immunostained for the cholangiocyte marker, CK19. Scale bar = 50 µm. Right panel displays the quantified data of digital image analysis of immunostained sections. (B) Representative images of FPPE mouse liver tissue sections immunostained for the myofibroblast marker, desmin. Scale bar = 150 µm. Digital image quantification is presented in the right panel. (C) Representative images of FPPE mouse liver sections stained for fibrosis with Sirius Red. Fast green was used as counterstain. Scale bar = 100 µm. Collagen was quantified using Sirius Red under plane-polarized light and is presented in the right panel. (D) Representative images of frozen mouse liver sections immunostained for the fibrillar collagen, COL1A1. The right panel shows the digital image quantification. (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001).
Figure 2 Ductular reaction and fibrosis are increased in cholestatic mice. (A) Representative images of FPPE liver tissue sections from WT, Trailfl/fl, and TrailΔmye mice were immunostained for the cholangiocyte marker, CK19. Scale bar = 50 µm. Right panel displays the quantified data of digital image analysis of immunostained sections. (B) Representative images of FPPE mouse liver tissue sections immunostained for the myofibroblast marker, desmin. Scale bar = 150 µm. Digital image quantification is presented in the right panel. (C) Representative images of FPPE mouse liver sections stained for fibrosis with Sirius Red. Fast green was used as counterstain. Scale bar = 100 µm. Collagen was quantified using Sirius Red under plane-polarized light and is presented in the right panel. (D) Representative images of frozen mouse liver sections immunostained for the fibrillar collagen, COL1A1. The right panel shows the digital image quantification. (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001).CC BY · PubMed Central
Figure 3 Cholangiocyte proliferation is similar whereas apoptosis is decreased in the cholangiocytes of cholestatic TrailΔmye mice as compared to the WT mice. (A) Representative images of FPPE mouse liver tissue sections from WT and TrailΔmye co-immunostained for the cholangiocyte marker, CK7 (green) and the proliferation marker, Ki-67 (red). Scale bar = 75 µm. Digital image quantification of CK7+Ki-67+ cholangiocytes is presented in the right panel. (B) Representative images of frozen mouse liver tissue sections co-immunostained for CK7 (green) and the apoptosis marker, cleaved caspase-3 (red). Red arrows point to CK7+ CC3+ cells, while yellow arrows point to CC3 staining in a different cell type. Scale bar = 50 µm. Digital image quantification of CC3 positive cholangiocytes is shown in the right panel. (*p < 0.05, ***p < 0.005, ****p < 0.001).
Figure 3 Cholangiocyte proliferation is similar whereas apoptosis is decreased in the cholangiocytes of cholestatic TrailΔmye mice as compared to the WT mice. (A) Representative images of FPPE mouse liver tissue sections from WT and TrailΔmye co-immunostained for the cholangiocyte marker, CK7 (green) and the proliferation marker, Ki-67 (red). Scale bar = 75 µm. Digital image quantification of CK7+Ki-67+ cholangiocytes is presented in the right panel. (B) Representative images of frozen mouse liver tissue sections co-immunostained for CK7 (green) and the apoptosis marker, cleaved caspase-3 (red). Red arrows point to CK7+ CC3+ cells, while yellow arrows point to CC3 staining in a different cell type. Scale bar = 50 µm. Digital image quantification of CC3 positive cholangiocytes is shown in the right panel. (*p < 0.05, ***p < 0.005, ****p < 0.001).CC BY · PubMed Central
Figure 4 Immunophenotyping of intrahepatic leucocytes using mass cytometry. (A) t-SNE plot showing the spatial distribution of the 28 immune cell clusters resolved by unsupervised, non-linear dimension reduction. Similar cells cluster proximally, while dissimilar cells are located further apart. Each cluster is numbered and identified in the label below. (B) Hierarchical clustering heatmap of immune cell cluster abundance for all experimental mice is shown. Experimental groups (Label: WT Wild Type, TRAIL = Trail∆mye) are clustered together. (C) t-SNE plots of immune cell cluster abundance for pooled cells (All) and for each experimental group (WT CON, WT DDC, and Trail∆mye DDC) is presented. Asterisks highlight the absence or the depletion of immune cell clusters within the experimental group. Arrows point to cell clusters that are abundant in the TrailΔmye mice. (D) Total number of recruited macrophages (representing the sum of clusters 21, 24, and 28) is graphically presented. These clusters were distinguished by the presence of markers, Ly6C and CX3CR1. (E) The mean intensity of all markers of cluster 22 is graphed. Red arrows point to the most dominant markers used to identify the cluster immune phenotype as neutrophils. (F) The abundance of cluster 22 for each experimental group is quantified. (G) Representative images of FPPE mouse liver sections immunostained for the macrophage marker, IBA-1 (in red) (upper panel; scale bar = 50 µm) and the neutrophil marker, MPO (lower panel; scale bar = 100 µm) are shown along with the corresponding, quantified data on the right. (*p < 0.05, **p < 0.01, and ***p < 0.005, ****p < 0.001).
Figure 4 Immunophenotyping of intrahepatic leucocytes using mass cytometry. (A) t-SNE plot showing the spatial distribution of the 28 immune cell clusters resolved by unsupervised, non-linear dimension reduction. Similar cells cluster proximally, while dissimilar cells are located further apart. Each cluster is numbered and identified in the label below. (B) Hierarchical clustering heatmap of immune cell cluster abundance for all experimental mice is shown. Experimental groups (Label: WT Wild Type, TRAIL = Trail∆mye) are clustered together. (C) t-SNE plots of immune cell cluster abundance for pooled cells (All) and for each experimental group (WT CON, WT DDC, and Trail∆mye DDC) is presented. Asterisks highlight the absence or the depletion of immune cell clusters within the experimental group. Arrows point to cell clusters that are abundant in the TrailΔmye mice. (D) Total number of recruited macrophages (representing the sum of clusters 21, 24, and 28) is graphically presented. These clusters were distinguished by the presence of markers, Ly6C and CX3CR1. (E) The mean intensity of all markers of cluster 22 is graphed. Red arrows point to the most dominant markers used to identify the cluster immune phenotype as neutrophils. (F) The abundance of cluster 22 for each experimental group is quantified. (G) Representative images of FPPE mouse liver sections immunostained for the macrophage marker, IBA-1 (in red) (upper panel; scale bar = 50 µm) and the neutrophil marker, MPO (lower panel; scale bar = 100 µm) are shown along with the corresponding, quantified data on the right. (*p < 0.05, **p < 0.01, and ***p < 0.005, ****p < 0.001).CC BY · PubMed Central
Figure 5 Diminished expression of TRAIL in cholestatic TrailΔmye mice facilitates the retention of DR subsets. (A) Representative images of FPPE liver tissue sections of Trail fl/fl and TrailΔmye mice immunostained for the cholangiocyte marker, CK19 (magenta), pan-macrophage marker, IBA-1 (green), TRAIL (red), and nuclei (DAPI, blue). Yellow arrows point to TRAIL present in IBA1+ macrophages adjacent to cholangiocytes. White arrow shows TRAIL in another cell type. Scale bar = 20 µm. (B) Hepatic gene expression of Tnfsf10 (TRAIL) is shown in cholestatic TrailΔmye mice. (C) Hierarchical clustering heatmap of differentially expressed genes in cholestatic WT and TrailΔmye mice were identified using spatial transcriptomics and filtered for genes of interest with an unbiased approach. The heatmap represents 2110 genes that were thus identified. Gene expression in cholestatic mice was normalized to gene expression in their respective control diet-fed mice. Differentially expressed genes in cholangiocytes and macrophages in the periportal and parenchymal segments are shown. Color codes for cell type (Cholangiocyte = grey, Macrophages = black), ROI (PanCK = magenta, IBA-1 = green), genotype (WT = blue, TrailΔmye = red), and location (periportal = brown, parenchymal = purple) are indicated in the first 4 rows of the heatmap. (D,E) Volcano plots for the PanCK+ cells and the IBA1+ cells highlight the upregulation of pro-fibrotic, pro-inflammatory, and chemoattractant genes with cholestatic liver injury. Red dashed lines indicate values of p < 0.05 on the Y axis and log2 fold change (-1 and 1) on the X axis. (F) Heatmap of select chemoattractant genes differentially expressed in the cholangiocytes of WT and TrailΔmye mice with cholestatic injury is presented. Gene expression of DDC-fed mice is normalized to their respective control diet-fed mice. (G,H) IPA analysis of the transcriptome of PanCK + and IBA1+ segments show the top signaling pathways activated with DDC diet-induced cholestatic liver injury. Red arrows point to pathways involved in inflammation, and hepatic fibrosis.
Figure 5 Diminished expression of TRAIL in cholestatic TrailΔmye mice facilitates the retention of DR subsets. (A) Representative images of FPPE liver tissue sections of Trail fl/fl and TrailΔmye mice immunostained for the cholangiocyte marker, CK19 (magenta), pan-macrophage marker, IBA-1 (green), TRAIL (red), and nuclei (DAPI, blue). Yellow arrows point to TRAIL present in IBA1+ macrophages adjacent to cholangiocytes. White arrow shows TRAIL in another cell type. Scale bar = 20 µm. (B) Hepatic gene expression of Tnfsf10 (TRAIL) is shown in cholestatic TrailΔmye mice. (C) Hierarchical clustering heatmap of differentially expressed genes in cholestatic WT and TrailΔmye mice were identified using spatial transcriptomics and filtered for genes of interest with an unbiased approach. The heatmap represents 2110 genes that were thus identified. Gene expression in cholestatic mice was normalized to gene expression in their respective control diet-fed mice. Differentially expressed genes in cholangiocytes and macrophages in the periportal and parenchymal segments are shown. Color codes for cell type (Cholangiocyte = grey, Macrophages = black), ROI (PanCK = magenta, IBA-1 = green), genotype (WT = blue, TrailΔmye = red), and location (periportal = brown, parenchymal = purple) are indicated in the first 4 rows of the heatmap. (D,E) Volcano plots for the PanCK+ cells and the IBA1+ cells highlight the upregulation of pro-fibrotic, pro-inflammatory, and chemoattractant genes with cholestatic liver injury. Red dashed lines indicate values of p < 0.05 on the Y axis and log2 fold change (-1 and 1) on the X axis. (F) Heatmap of select chemoattractant genes differentially expressed in the cholangiocytes of WT and TrailΔmye mice with cholestatic injury is presented. Gene expression of DDC-fed mice is normalized to their respective control diet-fed mice. (G,H) IPA analysis of the transcriptome of PanCK + and IBA1+ segments show the top signaling pathways activated with DDC diet-induced cholestatic liver injury. Red arrows point to pathways involved in inflammation, and hepatic fibrosis.CC BY · PubMed Central
Figure 6 Cxcl1 mRNA is significantly increased in the TrailΔmye cholangiocytes. (A) Representative images of FPPE mouse liver tissue sections showing Cxcl1 mRNA (red) expression by ISH, followed by immunostaining for CK19 (green) to define cholangiocytes. Scale bar = 10 µm. Some panels show zoomed images. (B) Cholangiocyte-specific Cxcl1 mRNA was quantified (*p < 0.05, **p < 0.01). (C) A schematic depicting the differing outcomes of DDC diet-induced cholestatic liver injury in WT and TrailΔmye mice. Depletion of TRAIL in myeloid cells results in the persistence of DR subsets, a source of pro-inflammatory chemoattractants. Neutrophils and fibroblasts accumulate in the liver leading to enhanced inflammation and increased fibrosis. The schematic was generated in Biorender.com.
Figure 6 Cxcl1 mRNA is significantly increased in the TrailΔmye cholangiocytes. (A) Representative images of FPPE mouse liver tissue sections showing Cxcl1 mRNA (red) expression by ISH, followed by immunostaining for CK19 (green) to define cholangiocytes. Scale bar = 10 µm. Some panels show zoomed images. (B) Cholangiocyte-specific Cxcl1 mRNA was quantified (*p < 0.05, **p < 0.01). (C) A schematic depicting the differing outcomes of DDC diet-induced cholestatic liver injury in WT and TrailΔmye mice. Depletion of TRAIL in myeloid cells results in the persistence of DR subsets, a source of pro-inflammatory chemoattractants. Neutrophils and fibroblasts accumulate in the liver leading to enhanced inflammation and increased fibrosis. The schematic was generated in Biorender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 8

Metadata

Authors
Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., Baez-Faria, M., Gutierrez, F., & Gores, G. J.
Affiliations
Mayo Clinic (US)
Corresponding author
Gores, Gregory J.
Venue
Scientific Reports
Published
2024-01-25
Volume
14
Issue
1
Pages
2145-2145
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4391228470
Cited by
8
References
32
Citations by year
2026: 4 · 2025: 3 · 2024: 1
FWCI
2.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • PSC Partners Seeking a Cure
  • National Center for Advancing Translational Sciences (KL2 TR002379)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK124182)
  • NIDDK-funded Optical Microscopy Core of Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
TRAIL, tumor necrosis factor-related apoptosis-inducing ligand, cholestatic liver injury, myeloid cells, macrophages, neutrophils, cholangiocytes, liver fibrosis, liver inflammation, CXCL1, cholestasis
MeSH terms
Animals, Cholestasis, Fibrosis, Ligands, Liver, Macrophages, Mice, Inbred C57BL, Tumor Necrosis Factor-alpha, Apoptosis, Mice, TNF-Related Apoptosis-Inducing Ligand

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury. https://app.cochat.ai/papers/10.1038/s41598-024-52710-3
The paper
Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., Baez-Faria, M., Gutierrez, F., & Gores, G. J. (2024). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury. Scientific Reports. https://doi.org/10.1038/s41598-024-52710-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.